reSee.it - Related Video Feed

Quan et al demonstrated that the introduction of DNA into a cell, even without integration, can trigger the oncogenic cGAS-STING pathway. The speaker claims that the presence of an SV40 origin of replication, a mammalian origin, in a vaccine grown in E. coli is reckless because it allows the plasmid DNA to replicate episomally in the host. The speaker alleges evidence suggests Pfizer, unlike Moderna, may have included this origin of replication due to carelessness. The speaker highlights concerns about nucleic acid persistence, noting that RT-PCR methods used in studies like Krausson and Rolchen may have amplified both DNA and RNA. The speaker suggests that prior studies assumed detected nucleic acids were RNA, but that further investigation using primers specific to the plasmid backbone might reveal the presence of residual plasmid DNA. The Krausson paper found nucleic acids present for thirty days in heart tissues, and the Rolchen paper found them for sixty days.

Tokyo Institute of Technology Professor Emeritus Murakami discusses the issue of DNA contamination in mRNA vaccines. Multiple researchers have reported the presence of DNA in these vaccines, including LANW0RDS sequences that can activate genes and increase the risk of cancer. The mRNA vaccines also contain spike protein genes that can remain in stem cells and continuously produce spike proteins, leading to immune system suppression and potential health problems. The induction of IGG4 antibodies by the vaccines can further disrupt the immune system and increase the risk of cancer. The presence of more DNA in the vaccines can intensify adverse reactions. The possibility of impurities, such as DNA, in different vaccine batches is a concern. Overall, DNA should not be present in vaccines.

"Packaged DNA fragments have been found en masse as vaccine contaminants." "Once they reach the nucleus, short DNA sequences have an increased propensity to insert into chromosomal DNA." "The possible consequences are unending." "Disruption of the exquisitely tuned network that controls cell division and differentiation can lead to cancer and to developmental defects." "Mutations in sperm and fertilized egg cells could render altered traits inheritable." "Cost effective procedures to reliably separate mass produced RNA from plasmids do not exist." "Contamination of RNA vaccines with plasmid DNA must therefore be expected to be the rule and not the exception." "Whoever propagates RNA vaccines as being safe and effective, whoever claims that nothing can happen to your genome, is either incredibly ignorant or endlessly evil."

The symposium covers the potential safety and threat of “replicating” vaccines, especially LepriCon (leprecon) vaccines, in the context of Covid-19 vaccines and genome‑editing concepts. The speakers present a chain of claims and concerns, some drawing on reports and others presenting theories about how these next‑generation vaccines could behave in humans and populations. Key points and claims presented - Emerging mechanisms and risks: The panel notes that blood vessel inflammation and thrombosis mechanisms are increasingly observed, including in vaccine contexts, with examples from individuals who needed limb amputation and others who developed severe vascular events after vaccination. One case involved a 70‑year‑old man who, after a third dose, developed embolic events necessitating shoulder joint surgery, and another where a 60‑year‑old man developed acute limb ischemia and died; both are presented as suggesting a serious vascular mechanism linked to vaccination, though causal connections are not established. - Replicating/vector vaccines and their concerns:荒川博士 and others discuss LepiCon vaccines as vaccines that replicate inside the body. The concept involves “replicating viral vectors” where the genome can mutate and evolve during replication. The green‑highlighted segment in a slide (the antigen gene) plus a blue/orange segment (replicating gene cassette) is used to describe how LepriCon vaccines are designed to carry viral genes and replicate, with the assertion that replication, mutation, and recombination can occur, potentially generating new variants inside the host. - Differences from conventional vaccines: The discussion contrasts LepriCon vaccines with standard mRNA vaccines. In conventional mRNA vaccines, messenger RNA is delivered and translated into antigen proteins, then degraded; in LepriCon vaccines, replicating RNA/DNA can persist and continue producing antigen, with mutation and recombination possible. The panel emphasizes that LepriCon vaccines use replicating/copying mechanisms and that the genetic material can be copied in ways that differ from natural human biology, potentially creating unpredictable variants. - Central dogma and exceptions: The speakers reference the central dogma (DNA → RNA → protein) but note exceptions in viruses, including RNA viruses that can reverse‑transcribe to DNA (retroviruses) and RNA viruses that replicate RNA directly. They discuss how LepriCon vaccines would rely on replicative processes that do not follow the usual linear flow and why this could complicate predictions about safety and behavior in humans. - Potential for unintended spread and environmental impact: A major concern raised is that self‑replicating vectors could spread beyond the vaccinated individual, via exosomes or other intercellular transport, creating secondary infections or non‑target spread. Exosomes could ferry replicating genetic material, raising fears of new infection chains or “outbreaks” stemming from the vaccine itself, and even suggesting the possibility of vaccination‑induced spread akin to an attenuated or modified pathogen. - Safety signals and immunology concerns: The discussion touches on immune system risks, including immune dysregulation, autoimmune phenomena, and unexpected inflammatory responses. IGG4‑related disease is highlighted as a potential adverse outcome post‑vaccination, with descriptions of glandular and systemic involvement and the idea that high IGG4 levels could have immunosuppressive effects that alter responses to infection or vaccination. The panel notes observed increases in certain immunoglobulin subclasses after multiple LepriCon doses and discusses the possibility of immune tolerance or enhanced immune responses that could be harmful. - Historical and theoretical context: References are made to past epidemics and speculative pandemics caused by misused or dangerous vaccine platforms, drawing on central molecular biology concepts and historical anecdotes about how vaccines can be designed and misused. The discussion frames LepriCon vaccines as a high‑risk platform that could, in theory, generate recombinants, escape mutations, or cause unintended immune and inflammatory consequences. - Clinical and regulatory implications: The speakers call for caution, arguing that more evidence is needed before approving or widespread use of LepriCon vaccines. They emphasize the need for long‑term observation and transparent communication about risks, and criticize the potential for insufficient understanding among healthcare workers and the public. They also urge that any future vaccine development should consider the possibility of genome editing, recombination, and exosome‑mediated spread, and stress the importance of not underestimating possible adverse effects. - Real‑world observations and skepticism about hype: Several speakers underscore that the danger is not merely hypothetical; there are reports of adverse events, including stroke‑like conditions, inflammatory diseases, and immune dysregulation in vaccinated individuals. They stress that the evolution and mutation of replicating vaccines could outpace current surveillance methods, and that “information manipulation” or lack of transparent reporting could mislead the public about risks. - Final reflections and call to action: The concluding messages advocate recognizing the potential failures of messenger RNA vaccines and acknowledging that both conventional and replicating platforms may carry risks. The speakers urge ongoing critical analysis, cautious progression, and robust verification of claims through transparent, independent investigation. They close with thanks to the organizers and a hope that the discussion may contribute to broader public awareness and informed decision‑making. Notable emphasis and unique considerations - The core concern centers on LepriCon vaccines’ replication, mutation, and potential to spread beyond the vaccinated person; exosome transport and genomic/cellular integration are highlighted as mechanisms that could generate new risks not present with non‑replicating vaccines. - The discussion stresses that IGG4 responses could become alarmingly high after certain doses, potentially leading to immunosuppressive effects or autoimmune phenomena, and presents IGG4‑related disease as a potential complication to monitor. - The speakers insist that safety and transparency are paramount, and that misinformation or optimistic narratives about rapid vaccine development could lead to harm if new platforms are adopted without comprehensive evaluation. Overall, the symposium foregrounds cautious scrutiny of replicating vaccine platforms, frames potential biological and regulatory risks, and calls for careful, evidence‑based assessment before broader deployment.

Moderna holds a patent for using RNA in vaccines, acknowledging that RNA is superior to DNA due to concerns about DNA-related problems like insertional immunogenesis and genotoxicity. The FDA claims to be unaware of any issues, but Moderna's own patent raises the same concerns about DNA. It appears that DNA is present in the RNA preparation as a contaminant, as it is used in the process of making RNA. Recent findings by scientists revealed large numbers of DNA fragments in the RNA preparation, including sequences that are not normally allowed in human use, such as an antibiotic resistance gene and sequences from simian virus 40. These DNA fragments can potentially lead to DNA damage, birth defects, and cancer.

Speaker 0 asks: "Do you think there's evidence that the changes to people to their genetic structure wrought by these vaccines could be passed on to their children?" Speaker 1 responds: "The McCullough Foundation, of which I am the vice president, we just published a person who had cancer of the bladder, which is a very severe cancer, in that tumor, so in the bladder cells that had become dysplastic, that messenger RNA was found in the cancerous cells of this tumor. So it seems to be integrating. Now the question is, is it integrating in a way that is can be passed on to the offspring, or is it so dysfunctional that it's killing the host before it can be passed on? And and I don't know that we yet know that, but remember, the science is the topography of ignorance. I mean, there's a lot about this that is is very, very concerning. There's also a study that this messenger RNA seems to have transcribed into liver cells."

The Pfizer and Moderna vaccines contain fragments of DNA, which can integrate into the genomic DNA of cells and become a permanent part of the cell. This poses a potential risk of autoimmune attacks and future cancer. The DNA contamination occurred during the production process, where a plasmid vector was used to scale up the production of the RNA template. The regulatory threshold for DNA in vaccines is outdated and not suitable for this new type of vaccine. The speaker believes that DNA sequencing should be done on vaccinated individuals' stem cells to determine if this theoretical risk has occurred. Informed consent is necessary, and the lack of transparency regarding the DNA contamination is concerning.

Mr. Kevin McKernan, a former leader at the Human Genome Project, discussed DNA contamination in Pfizer and Moderna vaccines. He highlighted the risks of insertional mutagenesis and integration into the genome, contradicting regulators' claims of little consequence. The DNA, found in lipid nanoparticles, can enter cells and potentially contribute to cancer. McKernan emphasized the inadequacy of current monitoring methods and called for a review of regulatory practices. The presence of DNA in these vaccines challenges existing safety standards and raises concerns about long-term effects.

The mRNA in vaccines can replicate, including the replication engine, leading to potential spread from person to person. Concerns exist about the inability to stop this replication, with unknown consequences for humanity. The spike protein in these vaccines can be toxic, affecting various tissues. Deployment of this technology in vaccines for humans is already happening, with over 4,000 people injected in Japan.

Self-amplifying RNA (saRNA) is being fast-tracked in the US after approval in Japan and Europe. SaRNA is similar to mRNA but replicates itself like a virus. Concerns are raised about its biodistribution and persistence, suggesting it could act as an STD. A white paper calls for a halt on saRNA vaccine deployment until comprehensive safety studies address contagious risks. It is argued that Moderna and Pfizer shots already shed and act as STDs, transmitting spike protein infections. SaRNA is designed to replicate and remain strong, potentially causing a contagious cancer-like disease. COVID shots may contain cancer-causing viruses like SV40, possibly with SV40 promoters to enhance their effectiveness. mRNA degrades over time, but saRNA is designed to make more of itself. There are ways to detox from mRNA, but not a self-replicator. Ultramethylene Blue is promoted for cell health, available at the Alex Jones store.

The FDA is fast tracking self-amplifying RNA (saRNA) vaccine platforms, a technology similar to COVID-era mRNA injections, potentially creating transmissible biological agents. Arcturus Therapeutics received FDA fast track designation for its saRNA vaccine candidate for pandemic influenza A virus H5N1, funded by BARDA and the Gates Foundation. Unlike traditional mRNA, saRNA replicates within cells, increasing toxicity, extending persistence, and raising transmissibility concerns. Attorney Tom Renz expresses alarm, stating clinical trials are dangerous and saRNA vaccines could mutate and become transmissible. Yale studies show mRNA persisting in the system for over 700 days post-vaccination, raising concerns about saRNA lasting indefinitely. Renz cites potential SV40 contamination and recombination with wild-type viruses as risks. There are three mechanisms by which saRNA could become transmissible: recombination, contamination, and hyper-stability. Renz criticizes AI's biased assessment of vaccine safety, noting the need to argue extensively with AI systems to reveal potential issues. He warns against AI-driven personalized cancer drugs without long-term safety tests.

- The mRNA on plasmids was produced, and after processing, much DNA from plasmids remained; Kevin MacKinnon found that vials were full of plasmid DNA, the whole plasmid and parts of it, and this was published. Authorities claimed it doesn’t matter and that vaccines have saved millions of lives, so why not have some DNA in them. - The DNA in the vaccine vials was packaged in lipid nanoparticles and was shown by colleagues last year (the INMODIA publication) to enter human cells in culture and remain stable in cells for days, as did the mRNA. Despite this, the message given was to poof, never mind, don’t worry, be happy. - A radical change occurred due to a discovery by Kevin MacKinnon three weeks ago: during transcription on the chromosome, byproducts are generated; some mRNA strands do not detach from the DNA where they’re formed, creating hybrids of DNA and RNA that come off together. These hybrids are dangerous. - In cells, an enzyme called RNase H takes care of these sparks and extinguishes them immediately; otherwise they can cause damage to the chromosome, potentially lighting “fires” on the chromosomes. If not extinguished, the fires can cause diverse damage depending on where they occur, potentially leading to illnesses described in medical textbooks, including tumors (neoplastic disease), autoimmune disease, developmental impairment, birth defects, or death. - The speaker asserts these hybrids and their mishandling could lead to a broad range of illnesses, and emphasizes that this situation is not limited to the COVID vaccine but applies to all Moderna RNA vaccines, including new Moderna RNA vaccines entering the market, such as a flu vaccine, and mentions veterinary RNA vaccines as well. - The claim is made that these vaccines will be heavily contaminated with deadly dangerous hybrids, and it is the duty of authorities and controlling authorities to stop proceeding and not turn away; otherwise they will face court for not fulfilling their duties. The speaker has been giving interviews and asserts this narrative is spreading worldwide, framing it as akin to attempted murder and urging physicians to refuse vaccination.

The speaker discusses issues with RNA vaccines, such as frame shifting and template switching, potentially leading to the production of abnormal proteins. They highlight concerns about mitochondrial sequences in vaccines causing adverse effects in patients. The conversation delves into the risks of amyloidogenic proteins and their ability to trigger a chain reaction of misfolding, leading to serious health implications. The speaker emphasizes the need for further research and vigilance in monitoring potential risks associated with RNA vaccines.

A new version of mRNA technology called self-replicating mRNA is emerging. This platform was a competitor to the mRNA platform that was settled upon. There are protests in Japan over self-replicating mRNA vaccines, also called replicons. The original mRNA platform turned people's cells into vaccine factories. To make the mRNA vaccines work, the mRNA transcript was stabilized with pseudouridine. All of the uracils were replaced by something chemically similar to stabilize the molecules. The claim that the mRNA molecules were short-lived was false, as they had been hyper-stabilized. Self-replicating mRNAs borrow machinery from alphavirus. They include the gene for the antigen along with genes for proteins that allow the RNA to copy itself. Instead of stabilizing a single mRNA molecule, the mRNA is allowed to duplicate itself.

The transcript discusses self-amplifying replicon mRNA injections and asserts that they are being deployed for both humans and animals globally. It states that the UK approved Arcturus Therapeutics’ self-amplifying COVID-19 vaccine for adults over 18, and that the European Union previously approved the same inoculation for adults, placing it in both the EU and the UK. It also claims that Japan approved it in 2023, and that India has approved these replicon injections as well, indicating a global rollout. It highlights that in the United States, the USDA approved the self-amplifying mRNA particle injections for pets, specifically mentioning Merck’s Novavax NXT for dogs and cats, and asserts that this is being injected into pets and that shedding onto human owners across the US is possible. It notes that the FDA has fast-tracked an H5N1 bird flu replicon injection trial, emphasizing concern about these developments. The speaker outlines purported dangers of these replicating genetic materials, including the possibility of shedding from humans to humans or from pets to humans, and the potential for recombination with wild viruses to create chimeric mutants. It emphasizes the claimed approval of Arcturus Therapeutics’ injection “everywhere in the clinical trials” and then provides adverse event statistics: eighty-five percent suffered systemic adverse events, and fifteen percent required medical attention. A Uganda study is cited, claiming that the replicon injections induced severe blood abnormalities in ninety-three percent of recipients, with thrombocytopenia, lymphopenia, and neutropenia reported, implying degraded immune systems and increased risks of internal bleeding in a majority of participants. The Uganda study is also described as showing eighty-five percent experiencing vomiting, high fevers, and feeling absolutely terrible. The speaker concludes with a strong stance against these injections, calling them a “self amplifying assault on humanity” and arguing that they should be pulled off the market and banned for human use. The overall message is a warning about global deployment, potential shedding and recombination risks, significant adverse event rates, and a call to ban self-amplifying mRNA injections for humans. The named entities include Arcturus Therapeutics, Merck, Novavax NXT, and references to regulatory actions in the UK, EU, Japan, India, and the US.

Tokyo Institute of Technology Professor Emeritus Murakami discusses the issue of DNA contamination in mRNA vaccines. Multiple researchers have confirmed the presence of DNA in these vaccines, including LANW0RDS sequences and viral gene sequences necessary for gene expression. This contamination can lead to the activation of germination genes and potentially increase the risk of cancer. Additionally, the mRNA vaccines can induce the production of IGG4, which can suppress immune function and lead to the proliferation of cancer cells. The presence of more DNA in the vaccines can result in stronger immune reactions and potential side effects. The possibility of impurities, such as DNA, in vaccine batches is a concern. DNA should not be present in vaccines as it can cause adverse effects.

The mRNA platform is effective but has a flaw: it can cause autoimmune disorders by producing foreign proteins in cells. The challenge is to target only specific cells and avoid damage to vital organs. The pandemic allowed the emergency use authorization of mRNA vaccines, bypassing safety measures. However, a large portion of the population has already accepted this technology. To address the issue, a solution could be to replace the spike protein with a different protein that doesn't have flaws. But if the problem lies in any foreign protein transcribed by cells, the immune system may still target vital organs.

Moderna has a patent on the use of RNA for vaccines (patent number 2019-024-0317-A1). In that patent, Moderna explicitly acknowledges that RNA is superior to DNA for vaccine purposes because of “problems” including the possibility of insertional immunogenesis, which could lead to the activation of oncogenes or the integration of tumor suppressor genes. The transcript says that while the FDA says it is not aware of any concerns, Moderna’s own patent lays out the same concerns about DNA and insertional immunogenesis and genotoxicity, and that Moderna “knows it.” The discussion then turns to DNA as a contaminant. The transcript says DNA is left in because, in “process two,” circular DNA is purified from bacteria to make RNA; RNA makes protein; then the DNA is degraded and must be purified away from the RNA. It says the process is apparently not very good, and that DNA fragments were detected after some scientists in the U.S. and Canada obtained unopened vials with clear chain of custody, sampled them, and performed deep sequencing to reconstruct what circular plasmid DNA looked like in the RNA preparation. The transcript claims that these DNA fragments were not disclosed to the public. It adds that the reconstructed sequences include sequences “normally not allowed” in anything going into humans, including an antibiotic resistance gene for kanamycin or neomycin. It also says sequences from simian virus 40 (SV40) are present, specifically highly active promoter sequences. The transcript states that FDA older regulations said these must be avoided because they confer additional risk for insertional mutagenesis. The transcript further claims that when Pfizer provided documents to the FDA, EMA, and Health Canada, Pfizer took standard plasmid maps generated by publicly accessible programs and deleted the notation indicating SV40 sequences. It then says that the FDA did not reconstruct raw DNA sequences to check these maps and instead relied on Pfizer’s submissions. The transcript attributes the emergence of these findings to researchers performing work “akin to the lot release testing that is not happening.” When asked about downstream bad outcomes, the transcript says the outcomes associated with DNA damage include birth defects and cancer.

The Pfizer vaccine contains not only mRNA but also plasma DNA from the vector used in its production. I sequenced samples from two batches of the vaccine in Colombia and found this DNA, which raises concerns about potential health risks. This DNA could integrate into the genomic DNA of cells, leading to permanent changes. Such integration poses theoretical risks, including autoimmune responses and cancer, depending on where the DNA inserts itself in the genome. While these risks may be rare, they warrant investigation to understand their implications better.

The panel discusses replication (replicon) vaccines and their potential dangers, focusing on how they differ from conventional messenger RNA (mRNA) vaccines and what new risks might emerge as this technology develops. Key points and concerns raised - Replicon vaccines concept and fundamental differences - Replicon vaccines use replication-capable genetic material, so the embedded genetic information not only makes antigen proteins but also multiplies inside the cell. They are described as having both constitutive function (the ability to make proteins) and, crucially, the capacity to replicate, which distinguishes them from traditional, non-replicating mRNA vaccines. - It is explained that replication introduces additional mutation and recombination opportunities, because the RNA genome is copied more than once, and the process can produce variants that differ from the original design. - Central dogma exceptions and viral biology - The speakers explain that while the central dogma (DNA → RNA → protein) generally governs biology, some viruses violate this, with RNA viruses that replicate via RNA-dependent replication and even some reverse-transcribing retroviruses that convert RNA to DNA and integrate into genomes. This context is used to frame why replicon vaccines could behave unpredictably. - Potential risks of replication and spread - A core concern is that the replicon approach might allow the vaccine genome to spread beyond the initial target cells, potentially reaching other cells and tissues, or even spreading to other people via exosomes or other means. Exosomes can transport DNA, RNA, and proteins between cells; thus, the replicon genome could in theory be disseminated. - The possibility of homologous or heterologous recombination between replicon genomes and wild-type viruses could yield new variants. The panel emphasizes the difficulty of controlling such recombination in a living system. - Specific material and design considerations - The use of viral components like spike protein genes in replicon vaccines raises concerns about how these proteins might mutate or recombine during replication, potentially altering antigen presentation or safety. - A concern is raised about the lack of repair mechanisms in RNA replication (as opposed to DNA replication), which could make error rates higher and lead to unpredictable changes. - The panel notes that current replicon vaccine designs (including those using alphavirus backbones) inherently carry high mutation and recombination risk, and that the replicating systems may encounter unpredictable evolutionary dynamics inside the human body. - Safety signals and clinical anecdotes - The speakers cite cases of adverse events temporally associated with vaccines, including vascular inflammation and thrombosis, stroke-like events, and myocarditis, to illustrate that immune responses to vaccines can be complex and occasionally severe. They emphasize that such observations do not establish causality, but argue they warrant careful scrutiny. - There are references to cases of acute vascular and neural complications following repeated vaccination, and to broader immune dysregulation phenomena, including IGG4-related disease and immune dysregulation syndromes that can involve multiple organs. - One example concerns a patient who developed sudden limb problems after the third dose, requiring surgery; another describes myocardial involvement after multiple doses and subsequent inflammatory sequelae. - DNA contamination and analytical findings - Kevin McKernan’s analysis of certain Japanese CoronaVac vaccines is cited: both DNA contamination and the presence of SV40 promoter elements were detected in some vaccine lots, with DNA amounts exceeding some regulatory benchmarks in at least one case. The concern is that DNA contamination, or the presence of promoter sequences, could influence integration or expression in unintended ways. - It is noted that vaccines using lipid nanoparticles can potentially deliver nucleic acids into cells; in the presence of exons or promoter sequences, there could be unintended cellular uptake and expression. - Implications for public health and policy - The panel underscores the need for caution, thorough investigation, and long-term observation of any replication-based vaccine platform before broad deployment. There is a call to evaluate risks, monitor long-term outcomes, and consider the possibility that replication-competent constructs could drive unforeseen evolutionary dynamics within hosts or communities. - There is contention about how information is communicated to the public, with particular emphasis on avoiding misinformation while ensuring that scientific uncertainties are transparently discussed. - Broader scientific context and forward-looking stance - The speakers discuss how the field’s approach to gene-based vaccines is evolving rapidly, and they stress that the compatibility of replicon systems with human biology is not yet fully understood. - They frame their discussion as not merely about current vaccines but about the trajectory of vaccine platforms: if replication-based or self-dispersing systems prove too risky or unpredictable, the prudent path might be to favor conventional, non-replicating strategies until safety, efficacy, and containment of unintended spread are more firmly established. Closing and takeaways - The session closes with emphasis on careful evaluation of replicon vaccines, awareness that viral genetics can behave differently in humans than in theory, and a call for continued discussion, independent verification, and transparent communication as the technology develops. - Throughout, speakers acknowledge the complexity of immune responses to vaccines, the potential for unexpected adverse events, and the importance of safeguarding public health while advancing vaccine science.

The conversation centers on concerns about self-replicating mRNA (replicon) technology. The speaker argues that, given media coverage in 2024 about side effects of regular mRNA and reports of deaths in Japan, the government should immediately halt self-replicating mRNA. They reference a Substack article titled "Japan's plan to destroy the world," claiming replicon technology is extraordinarily dangerous—“beyond nuclear weapons.” The speaker describes a replicon as “the nuclear weapon of biology,” comparing it to a device that can copy itself and set a timer to explode years later (one year, ten years, fifty years). They emphasize that a replicon has the power to copy itself and to steal genes from other species, calling it “omnipotent” and “the omnipotent virus.” The doctor (referred to as Doctor Nagasaki) is pressed for comment, with the speaker noting that more copies of a replicon in the environment increase the likelihood of producing a deadly variant that can spread with minimal symptoms. They explain, from a natural selection perspective, that the evolutionary pressure on a replicon is to cause as few symptoms as possible to allow the host to continue normal daily activities, thereby maximizing transmission. The discussion also includes a brief mention of monitoring a chat discussion, indicating engagement with the audience.

The Pfizer vaccine is contaminated with plasma DNA, not just mRNA. This DNA is the DNA vector used as the template for the in vitro transcription reaction. This was discovered by sequencing vials of Pfizer vaccine from Colombia. It's surprising that there's any DNA in there. The speaker is alarmed about the possible consequences of this, including rare but serious side effects like death from cardiac arrest. Mixing DNA with a lipid complex allows it to enter cells and become a permanent fixture. This is a real hazard for genome modification of long-lived somatic cells, like stem cells, and could cause a sustained autoimmune attack. There is also a very real theoretical risk of future cancer in some people. The risk is not zero and it may be high enough that we ought to figure out if this is happening or not.

The speaker discusses claims about modified RNA (MOD RNA) vaccines and DNA contamination in plasmids. They state that after creating MOD RNA on plasmids, the plasmid DNA remained and much of it could not be destroyed. They reference Kevin MacKurn’s discovery three years ago that vials were full of plasmid DNA, the whole plasmid and parts of it, and note that authorities allegedly minimized the issue, arguing that it doesn’t matter and that vaccines have saved millions of lives. The speaker asserts that the DNA in the vaccine vials was packaged in lipid nanoparticles and that this DNA would enter human cells. They reference colleagues’ publication last year (the INMODEO publication) showing that the DNA in the vaccine vials entered cells in culture and remained stable in cells for days, just as the MOD RNA did. Despite this, they say authorities dismissed the concerns with reassurance that nothing would happen. A pivotal point is attributed to a recent discovery by Kevin MacKinnon, claimed to be three weeks old, about what happens during transcription in the chromosome. The speaker explains that during production, byproducts occur and some mRNA strands do not detach from the DNA where they are formed, resulting in hybrids of DNA and RNA that come off together. The hybrids are described as dangerous, akin to “sparks of a sparkler,” and the speaker emphasizes that RNase H is an enzyme in the cell that takes care of these sparks and extinguishes them immediately. The speaker states that normal physicians don’t know about this, and they had to read up on RNase H after Jessica urged them to. The claimed consequence of failing to extinguish these hybrids is damage to the chromosome, with the metaphor that fires could light up and damage where they occur. The speaker asserts this could lead to “any illness that you see in the textbooks of medicine,” including tumors, neoplastic disease, autoimmune disease, developmental impairment, and death. They warn that the book of life—the genes and chromosomes—could be set on fire if these hybrids are not neutralized. The speaker says they have given interviews weekly, including one with Gary Null, and allege that this information is spreading worldwide. They claim that this situation is akin to attempted murder and exhort physicians globally not to participate, promising that those who do will be charged. They claim this issue is not limited to COVID vaccines but applies to all MOD RNA vaccines, including a flu MOD RNA vaccine now in use, and possibly veterinary vaccines, which they claim will be heavily contaminated with deadly dangerous hybrids. They urge authorities and controlling bodies to act, warning that they will face court if they fail to address the issue.

RNA sequencing of the Moderna vaccine's three prime ends suggests a possible mechanism for RNA persistence: in vivo re-adenylation. The data indicates plasmid DNA contamination despite efforts to reduce it. The data also reveals contamination from other mRNA vaccines in Moderna's pipeline. The speaker suggests that with widespread DNA sequencing capabilities, tolerating incorrect RNA sizes in vaccines is irresponsible. Sequencing before approval would have allowed for a better understanding of low RNA scores before global administration.

Tokyo Institute of Technology Professor Emeritus Mr. Murakami and I would like to share some information. In March, it was discovered that there is a significant amount of DM mixed in with the RNA, which was supposed to only contain RNA. Multiple researchers have confirmed this. One issue is that some LANWELISH, specifically SV4, promoter sequences are mixed in with the virus genes, which are necessary for gene expression. This can activate the immune system and cause various problems. DNA can induce mutations and easily enter cells, potentially disrupting important genes. The presence of LANWELISH promoter sequences in the virus can increase the risk of cancer. Vaccines that suppress the immune system can further increase the risk of cancer. It is important to minimize impurities in DNA, as they can cause inflammation and immune reactions. Different batches of vaccines may contain different impurities, such as DNA. DNA should not be introduced into cells.